Huaren Pharmaceutical Co.,Ltd.’s Net Profit Rose 59.9% in First Quarter of 2023

Huaren Pharmaceutical Co.,Ltd. (华仁药业股份有限公司) (300110.SZ) reported a net profit of 41.9 million yuan in the first quarter of 2023, up 59.9% year-on-year.

Meanwhile, the company posted 403.2 million yuan in revenue, up 4.6% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 2.5 billion yuan in total liabilities, with a liability-to-asset ratio of 48.6%.